Retrospective study of the correlation between the DNA repair protein alkyltransferase and survival of brain tumor patients treated with carmustine

Cancer Research

Volumn 56, Issue 4, 1996, Pages 783-788

  Belanich, Michael ^a   Pastor, Monica ^a   Randall, Terri ^a   Guerra, Denise ^a   Kibitel, Jeannie ^a   Alas, Lori ^a   Li, Ben ^b   Citron, Marc ^c   Wasserman, Patricia ^c   White, Agnes ^c   Eyre, Harmon ^d   Jaeckle, Kurt ^e   Schulman, Susan ^f   Rector, Dori ^g   Prados, Michael ^h   Coons, Stephen ⁱ   Shapiro, William ⁱ   Yarosh, Daniel ^a,j  

^a AGI Dermatics   (United States)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^d AMERICAN CANCER SOCIETY   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f UNIVERSITY OF UTAH   (United States)

^g Fred Hutchinson Cancer Research Center   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ BARROW NEUROLOGICAL INSTITUTE   (United States)

^j Applied Generics Inc   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CARMUSTINE; TRANSFERASE;

ARTICLE; BRAIN TUMOR; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CELL SUBPOPULATION; CROSS LINKING; DNA ALKYLATION; DNA REPAIR; HUMAN; HUMAN TISSUE; METHYLATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT FAILURE; XENOGRAFT;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS, ALKYLATING; BRAIN NEOPLASMS; CARMUSTINE; COMBINED MODALITY THERAPY; DNA REPAIR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; METHYLTRANSFERASES; MIDDLE AGED; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 13344282752     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Mahaley, M S , Mettlin, C , Natarajan, N., Laws, E. R., and Peace, B. B. National survey of patterns of care for brain-tumor patients. J Neurosurg., 71: 826-836, 1989.
2. Shapiro, W. Therapy of adult malignant brain tumors: what have the clinical trials taught us? Semin. Oncol., 13. 38-45, 1986.
3. 1-deoxyguanosinyl]-ethane in DNA treated with N,N′-bis(2-chloroethyl)-N-nitrosourea. Cancer Res., 42: 3102-3105, 1982.
4. 6-methylguanine-DNA methyltransferase in cell survival, mutagenesis and carcinogenesis. Mutat. Res., 145: 1-16, 1985.
5. 6-alkylguanine-DNA alkyltransferase. regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res., 50: 6119-6129, 1990.
6. Erickson, L., Laurent, G., Sharkey, N , and Kohn, K. DNA cross-linking and mono-adduct repair in nitrosourea-treated human tumour cells. Nature (Lond.), 288: 727-729, 1980.
7. - human tumor strains. Carcinogenesis (Lond.), 4: 199-205, 1983.
8. 6-methylguanine in DNA to inactivation by alkylating agents including chloroethylnitrosoureas. Cancer Res., 44: 2467-2474, 1984
9. 6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents. Proc. Natl. Acad Sci. USA, 87: 5368-5372, 1990
10. 6-benzylguanine on the sensitivity of human colon tumor xenografts to 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). Biochem. Pharmacol , 46: 285-290, 1993.
11. 6-methylguanine-DNA methyltransferase in individual human cells by quantitative immunofluorescence microscopy. Oncol. Res , 6 129-137, 1994.
12. 6-methylguanine-DNA methyltransferase in human brain tumors detected by activity assay and monoclonal antibodies Oncol. Res., 7: 49-55, 1995.
13. 6-methylguanine-DNA methyltransferase. Cancer Chemother. Pharmacol , in press, 1995.
14. Ross, R , Lim, C , Ashley, S., Goode, D , Traish, D , and Brada, M. Survival in patients with recurrent glioma as a measure of treatment efficacy: prognostic factors following nitrosourea chemotherapy. Eur. J. Cancer, 30A. 1809-1815, 1994.
15. 6-Alkylguanine-DNA alkyltransferase activity in human brain tumors. Cancer Lett , 55: 153-158, 1990.
16. 6-methylguanine-DNA methyltransferase activity in brain tumors and adjacent normal brain. Cancer Res., 53: 3416-3420, 1993
17. 6-methylguanine-DNA methyltransferase activity on chloroethylnitrosourea chemotherapy in brain rumors Int J Cancer, 55 76-81, 1993
18. Shapiro, J. Biology of gliomas heterogeneity, oncogenes, growth factors Semin Oncol., 13: 4-15, 1986.
19. Coons, S., and Johnson, C Regional heterogeneity in the DNA content of human gliomas. Cancer (Phila), 72. 3052-3060, 1993.
20. 6-methylguanine-DNA methyltransferase. J Biol. Chem., 265: 9563-9569, 1990.
21. Aabo, K., Roed, H., Vindelov, L , and Spang-Thomsen, M A dominant and resistant subpopulation causes regrowth after response to 1,3-bis(2-chloroethyl)-1-nitrosourea treatment of a heterogeneous small cell lung cancer xenograft in nude mice Cancer Res , 54: 3295-3299, 1994.